Skip to main content
Premium Trial:

Request an Annual Quote

Admera Health CardioGxOne Panel

Admera Health has launched the CardioGxOne next-generation sequencing panel for inherited cardiovascular disease. Developed as a joint venture between Admera Health and Health in Code, the test detects genomic variations in 213 genes related to familial cardiovascular diseases, and is designed to detect the genetic causes of sudden death in young individuals and athletes, such as cardiomyopathies, long QT, and Marfan syndrome. CardioGxOne combines the genetic and clinical information of more than 85,000 individuals from a proprietary database with a comprehensive interpretive report that is reviewed by specialized cardiology geneticists, Admera said.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.